RxDoctor Payments Data

Sajjad Sarwar, MD

Psychiatry · Grand Rapids, MINPI 1982839957

Payments from drug & device makers

$1,800in general payments, 2019–2025

Across 72 payments — averaging $25.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$867
  • E.r. Squibb & Sons, L.L.C.$317
  • Johnson & Johnson$188
  • AbbVie$169
  • Otsuka America Pharmaceutical, Inc.$79
  • Alkermes, Inc.$51
  • plus $129 from 5 others

What the payments were for

  • Food & beverage$1,57788%
  • Education$22312%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,800 in reported general payments places this provider in the 80th percentile of 1,166 psychiatry providers in Michigan.

See all psychiatry providers in Michigan

Medicare billing

Part B allowed, 2024
$25,554
Medicare patients
58
Services billed
292

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate14$55,928
Lurasidone Hcl16$21,984
Vilazodone Hcl17$1,849
Aripiprazole43$1,675
Trazodone Hcl78$1,031
Bupropion XlBupropion Hcl23$990
Duloxetine Hcl44$852
Buspirone Hcl80$804
Paliperidone ErPaliperidone15$802
Benztropine Mesylate46$711
Prazosin Hcl33$698
Venlafaxine Hcl ErVenlafaxine Hcl35$639
Alprazolam77$589
Clonazepam56$530
Quetiapine Fumarate31$511

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$188$55,92814 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,166 psychiatry providers in Michigan.

Other psychiatry in Grand Rapids

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →